Safety evaluation of a buffer used in the lyophilization of canine platelets: type I hypersensitivity reaction in dogs caused by bovine serum albumin

IntroductionThe present study was designed to evaluate the safety of substances generally used in the preparation of lyophilized platelet products (LPPs) because the possibility of an immune response to bovine serum albumin (BSA) was considered high when using previously described technology.Methods...

Full description

Bibliographic Details
Main Authors: Hee-Jae Choi, Mu-Young Kim, Hyun-Jung Han
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Veterinary Science
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fvets.2024.1344037/full
_version_ 1797316816596369408
author Hee-Jae Choi
Mu-Young Kim
Hyun-Jung Han
Hyun-Jung Han
author_facet Hee-Jae Choi
Mu-Young Kim
Hyun-Jung Han
Hyun-Jung Han
author_sort Hee-Jae Choi
collection DOAJ
description IntroductionThe present study was designed to evaluate the safety of substances generally used in the preparation of lyophilized platelet products (LPPs) because the possibility of an immune response to bovine serum albumin (BSA) was considered high when using previously described technology.MethodsAn intradermal skin test, followed by a drug provocation test, was conducted to observe adverse events and identify the substances responsible for an immune response. Five male beagles (2 years old) weighing 12–14 kg were used. The dogs were clinically healthy and had no history of medication use. An intradermal skin test was conducted with each substance [i.e., 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid, sodium chloride, potassium chloride, sodium bicarbonate, theophylline, trehalose, and BSA] used in the conventional freeze-dry method.ResultsIn the intradermal skin test, three dogs tested positive at the BSA injection site and showed clinical signs after the intradermal injection, including nausea and vomiting. For the drug provocation test, all dogs received two intravenous injections of an LPP buffer solution. The initial injection was devoid of BSA, whereas the subsequent injection contained BSA. The three dogs that had reacted to BSA in the intradermal skin test exhibited adverse events such as lethargy, vomiting, and nausea immediately after intravenous injection of the LPP buffer containing BSA. All dogs recovered uneventfully after symptomatic treatment in both tests.DiscussionThe high incidence and severity of type I hypersensitivity reactions observed in this study suggested that BSA is unsuitable as a component of canine LPP.
first_indexed 2024-03-08T03:23:52Z
format Article
id doaj.art-d58c48a0fc13421286b4db000d4dfec9
institution Directory Open Access Journal
issn 2297-1769
language English
last_indexed 2024-03-08T03:23:52Z
publishDate 2024-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Veterinary Science
spelling doaj.art-d58c48a0fc13421286b4db000d4dfec92024-02-12T04:46:32ZengFrontiers Media S.A.Frontiers in Veterinary Science2297-17692024-02-011110.3389/fvets.2024.13440371344037Safety evaluation of a buffer used in the lyophilization of canine platelets: type I hypersensitivity reaction in dogs caused by bovine serum albuminHee-Jae Choi0Mu-Young Kim1Hyun-Jung Han2Hyun-Jung Han3Department of Veterinary Emergency and Critical Care, College of Veterinary Medicine, Konkuk University, Seoul, Republic of KoreaDepartment of Veterinary Surgery, College of Veterinary Medicine, Konkuk University, Seoul, Republic of KoreaDepartment of Veterinary Emergency and Critical Care, College of Veterinary Medicine, Konkuk University, Seoul, Republic of KoreaKU Center for Animal Blood Medical Science, Konkuk University, Seoul, Republic of KoreaIntroductionThe present study was designed to evaluate the safety of substances generally used in the preparation of lyophilized platelet products (LPPs) because the possibility of an immune response to bovine serum albumin (BSA) was considered high when using previously described technology.MethodsAn intradermal skin test, followed by a drug provocation test, was conducted to observe adverse events and identify the substances responsible for an immune response. Five male beagles (2 years old) weighing 12–14 kg were used. The dogs were clinically healthy and had no history of medication use. An intradermal skin test was conducted with each substance [i.e., 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid, sodium chloride, potassium chloride, sodium bicarbonate, theophylline, trehalose, and BSA] used in the conventional freeze-dry method.ResultsIn the intradermal skin test, three dogs tested positive at the BSA injection site and showed clinical signs after the intradermal injection, including nausea and vomiting. For the drug provocation test, all dogs received two intravenous injections of an LPP buffer solution. The initial injection was devoid of BSA, whereas the subsequent injection contained BSA. The three dogs that had reacted to BSA in the intradermal skin test exhibited adverse events such as lethargy, vomiting, and nausea immediately after intravenous injection of the LPP buffer containing BSA. All dogs recovered uneventfully after symptomatic treatment in both tests.DiscussionThe high incidence and severity of type I hypersensitivity reactions observed in this study suggested that BSA is unsuitable as a component of canine LPP.https://www.frontiersin.org/articles/10.3389/fvets.2024.1344037/fulladverse eventbovine serum albuminhypersensitivitylyophilized platelet productplatelet transfusion
spellingShingle Hee-Jae Choi
Mu-Young Kim
Hyun-Jung Han
Hyun-Jung Han
Safety evaluation of a buffer used in the lyophilization of canine platelets: type I hypersensitivity reaction in dogs caused by bovine serum albumin
Frontiers in Veterinary Science
adverse event
bovine serum albumin
hypersensitivity
lyophilized platelet product
platelet transfusion
title Safety evaluation of a buffer used in the lyophilization of canine platelets: type I hypersensitivity reaction in dogs caused by bovine serum albumin
title_full Safety evaluation of a buffer used in the lyophilization of canine platelets: type I hypersensitivity reaction in dogs caused by bovine serum albumin
title_fullStr Safety evaluation of a buffer used in the lyophilization of canine platelets: type I hypersensitivity reaction in dogs caused by bovine serum albumin
title_full_unstemmed Safety evaluation of a buffer used in the lyophilization of canine platelets: type I hypersensitivity reaction in dogs caused by bovine serum albumin
title_short Safety evaluation of a buffer used in the lyophilization of canine platelets: type I hypersensitivity reaction in dogs caused by bovine serum albumin
title_sort safety evaluation of a buffer used in the lyophilization of canine platelets type i hypersensitivity reaction in dogs caused by bovine serum albumin
topic adverse event
bovine serum albumin
hypersensitivity
lyophilized platelet product
platelet transfusion
url https://www.frontiersin.org/articles/10.3389/fvets.2024.1344037/full
work_keys_str_mv AT heejaechoi safetyevaluationofabufferusedinthelyophilizationofcanineplateletstypeihypersensitivityreactionindogscausedbybovineserumalbumin
AT muyoungkim safetyevaluationofabufferusedinthelyophilizationofcanineplateletstypeihypersensitivityreactionindogscausedbybovineserumalbumin
AT hyunjunghan safetyevaluationofabufferusedinthelyophilizationofcanineplateletstypeihypersensitivityreactionindogscausedbybovineserumalbumin
AT hyunjunghan safetyevaluationofabufferusedinthelyophilizationofcanineplateletstypeihypersensitivityreactionindogscausedbybovineserumalbumin